Company profile: SurgRx
1.1 - Company Overview
Company description
- Provider of laparoscopic vessel fusion tools for surgical hemostasis.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to SurgRx
Alesi Surgical
HQ: United Kingdom
Website
- Description: Provider of surgical smoke management and visibility solutions that improve the safety, efficacy and outcomes of laparoscopic procedures, including Ultravision, an electrostatic precipitation system that minimizes surgical smoke without gas exchange; Ionwand, a device that creates negatively charged ions to clear smoke; and Ultravision2, a next‑generation generator optimizing Ultravision energy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alesi Surgical company profile →
Centerline Biomedical
HQ: United States
Website
- Description: Provider of the IOPS (Intra-Operative Positioning System), a 3D surgical navigation and visualization technology that improves endovascular procedure outcomes and reduces radiation exposure; used in FDA-cleared Endovascular Aortic Repair, Peripheral Artery Disease procedures, and structural heart interventions. Cleveland Clinic spin-off.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Centerline Biomedical company profile →
Minimally Invasive Devices
HQ: United States
Website
- Description: Provider of minimally invasive surgical tools, notably the FloShield system to enhance laparoscopic visualization. Products include FloShield Plus and FloShield Air using Vortex Barrier Technology to direct dry CO2 for continuous defogging and protection from condensation, debris, and smoke, and Flo-X in situ for intra-operative lens cleaning with a biocompatible surfactant without scope removal.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Minimally Invasive Devices company profile →
Misonix
HQ: United States
Website
- Description: Provider of ultrasonic surgical devices and platforms, including aspirators for soft and hard tissue removal and instruments for laparoscopic cutting, plus a portfolio of bone graft and scaffold solutions such as BoneScalpel, OSTEOAMP SELECT (Flowable, Fibers, Sponges), PUREBONE, and SIGNAFUSE.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Misonix company profile →
Hemostatix
HQ: United States
Website
- Description: Provider of thermal scalpel systems delivering surgical precision, visualization, and control. Products include Hemostatix Thermal Scalpel using thermal energy to seal blood vessels while cutting without electric current; Precision 8400 Controller maintaining blade temperature via Virtual Temperature Sensing; and a scalpel handle with temperature, incision, angle, and pressure control plus visual/tactile feedback.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hemostatix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for SurgRx
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to SurgRx
2.2 - Growth funds investing in similar companies to SurgRx
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for SurgRx
4.2 - Public trading comparable groups for SurgRx
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →